Workday, Inc. 8-K
Research Summary
AI-generated summary
Workday, Inc. Appoints Aneel Bhusri as CEO; Carl Eschenbach Resigns
What Happened
Workday announced that its Board appointed co‑founder Aneel Bhusri as Chief Executive Officer effective February 6, 2026; he will remain Chair of the Board. Carl Eschenbach ceased serving as CEO and resigned from the Board effective the same date. The company filed the appointment and related compensation and separation details in an 8‑K on February 9, 2026.
Key Details
- Aneel Bhusri appointment effective February 6, 2026; he remains Chair and is a co‑founder and long‑time director. He is party to a stock voting agreement with co‑founder David Duffield covering Class B shares representing ~68% of voting power (as of Jan 31, 2026).
- Compensation for Bhusri: initial annual base salary of $1,250,000 and an annual target cash bonus up to 200% of base salary beginning in Workday’s fiscal year ending Jan 31, 2027.
- Equity awards for Bhusri (expected grant date March 5, 2026): a time‑based RSU grant with grant‑date value $60,000,000 vesting over 4 years (1/4 at one year, then quarterly 1/16ths) and a performance‑based RSU (PVU) grant with grant‑date value $75,000,000 tied to multi‑year stock price targets over a five‑year performance period. No additional equity awards expected until 2027.
- Separation for Carl Eschenbach: lump sum cash payment of $3,601,355 (severance + estimated COBRA premiums) and accelerated vesting totaling 139,773 shares (time‑based and price‑achieved RSUs that would have vested in the next 12 months) plus accelerated vesting of 24,153 shares (first annual vest of his April 2025 RSU). He is eligible under Workday’s Executive Severance and Change in Control Policy; his Separation Agreement is attached as Exhibit 10.1.
Why It Matters
A leadership change at the CEO level is material for investors because it affects strategy, continuity, and governance. Bhusri is a founder with substantial voting alignment with co‑founder Duffield, which may affect board control and strategic direction. The compensation package includes large equity awards (combined potential grant value of $135M) that could affect future dilution and executive incentives; Eschenbach’s severance and accelerated vesting have modest short‑term cash and share impacts disclosed in the filing. The 8‑K provides the concrete terms investors can use to assess governance and potential shareholder value effects.